Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

In 2019, Fässler et al showed in this journal that the presence of tumor-associated antibodies correlated with response to immune checkpoint inhibitor treatment in patients with metastatic melanoma. The results of this study suggested that tumor-associated antibodies directed against melanocyte-diff...

Descripción completa

Detalles Bibliográficos
Autores principales: de Joode, Karlijn, Veenbergen, Sharon, Kransse, Claudia, Kortleve, Dian, Debets, Reno, Mathijssen, Ron H J, Joosse, Arjen, Schreurs, Marco W J, Van der Veldt, Astrid A M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906380/
https://www.ncbi.nlm.nih.gov/pubmed/36750254
http://dx.doi.org/10.1136/jitc-2022-006467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906380/
https://www.ncbi.nlm.nih.gov/pubmed/36750254
http://dx.doi.org/10.1136/jitc-2022-006467

Ejemplares similares